STEAP4
Metalloreductase STEAP4
Also known as: FLJ23153, SchLAH, STAMP2, STEA4_HUMAN, TIARP, TNFAIP9
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q687X5
- Gene
- STEAP4
- Ensembl
- ENSG00000127954
- Chromosome
- 7
- Canonical length
- 459 aa
- Protein class
- Enzymes, Predicted membrane proteins, Transporters
- Subcellular location
- Nucleoplasm,Plasma membrane
- Quaternary structure
- Homotrimer
OverviewNCBI Gene
The protein encoded by this gene belongs to the STEAP (six transmembrane epithelial antigen of prostate) family, and resides in the golgi apparatus. It functions as a metalloreductase that has the ability to reduce both Fe(3+) to Fe(2+) and Cu(2+) to Cu(1+), using NAD(+) as acceptor. Studies in mice and human suggest that this gene maybe involved in adipocyte development and metabolism, and may contribute to the normal biology of the prostate cell, as well as prostate cancer progression. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2011]
Canonical amino-acid sequenceUniProt
459 residues, UniProt reviewed canonical sequence.
>Q687X5|STEAP4
1 MEKTCIDALP LTMNSSEKQE TVCIFGTGDF GRSLGLKMLQ CGYSVVFGSR NPQKTTLLPS
61 GAEVLSYSEA AKKSGIIIIA IHREHYDFLT ELTEVLNGKI LVDISNNLKI NQYPESNAEY
121 LAHLVPGAHV VKAFNTISAW ALQSGALDAS RQVFVCGNDS KAKQRVMDIV RNLGLTPMDQ
181 GSLMAAKEIE KYPLQLFPMW RFPFYLSAVL CVFLFFYCVI RDVIYPYVYE KKDNTFRMAI
241 SIPNRIFPIT ALTLLALVYL PGVIAAILQL YRGTKYRRFP DWLDHWMLCR KQLGLVALGF
301 AFLHVLYTLV IPIRYYVRWR LGNLTVTQAI LKKENPFSTS SAWLSDSYVA LGILGFFLFV
361 LLGITSLPSV SNAVNWREFR FVQSKLGYLT LILCTAHTLV YGGKRFLSPS NLRWYLPAAY
421 VLGLIIPCTV LVIKFVLIMP CVDNTLTRIR QGWERNSKHLocalizationUniProt · AlphaFold · HPA
Whether an antibody against STEAP4 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 6
- Mean surface accessibility (rSASA)
- 0.3
- Highest tissue expression
- 107 nTPM
Expression across tissuesHPA
Tissue
- adipose tissue: 107 nTPM
- breast: 65 nTPM
- lung: 64 nTPM
- prostate: 56 nTPM
- thyroid gland: 49 nTPM
- adrenal gland: 44 nTPM
Single-cell type
- pericytes: 1,116 nCPM
- neutrophils: 826 nCPM
- conjunctival goblet cells: 311 nCPM
- alveolar cells type 2: 288 nCPM
- transitional alveolar cells: 283 nCPM
- respiratory secretory cells: 272 nCPM
Immune cell
- neutrophil: 162 nTPM
- classical monocyte: 13 nTPM
- total PBMC: 3.2 nTPM
- eosinophil: 1.4 nTPM
- myeloid DC: 1 nTPM
- intermediate monocyte: 0.8 nTPM
Brain region
- choroid plexus: 39 nTPM
- cerebellum: 9.1 nTPM
- hippocampal formation: 6.4 nTPM
- cerebral cortex: 6.3 nTPM
- medulla oblongata: 6.1 nTPM
- hypothalamus: 5.8 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.03
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.84
- DepMap mean gene effect
- 0.18
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- cupric reductase (NADH) activity
- electron transfer activity
- FAD binding
- ferric-chelate reductase (NADPH) activity
- heme binding
- metal ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of STEAP4 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads STEAP4 as an antibody target. Whether an autoantibody or antibody against STEAP4 could matter depends on whether native STEAP4 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
STEAP4 is annotated at the cell surface, where native STEAP4 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label STEAP4 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...